These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7097888)

  • 1. Dopamine agonists for polycystic ovary disease?
    González ER
    JAMA; 1982 Aug; 248(5):514. PubMed ID: 7097888
    [No Abstract]   [Full Text] [Related]  

  • 2. Bromocriptine response in normoprolactinemic patients with polycystic ovary disease: a preliminary report.
    Seibel MM; Oskowitz S; Kamrava M; Taymor ML
    Obstet Gynecol; 1984 Aug; 64(2):213-9. PubMed ID: 6234484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polycystic ovary syndrome with excess of prolactin].
    Ataniiazova OA; Orlova VG; Smetnik VP; Afonina LI
    Akush Ginekol (Mosk); 1990 Apr; (4):42-4. PubMed ID: 2143054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of bromocryptin in polycystic ovary syndrome].
    Fuhrer J; Cheviakoff S; Rubio V
    Rev Chil Obstet Ginecol; 1989; 54(6):364-9; discussion 369-70. PubMed ID: 2485372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
    Parsanezhad ME; Alborzi S; Jahromi BN
    Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of bromocriptine treatment on luteinizing hormone secretion in polycystic ovary syndrome.
    Falaschi P; Rocco A; del Pozo E
    J Clin Endocrinol Metab; 1986 Feb; 62(2):348-51. PubMed ID: 3510225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromocriptine in obstetrics and gynaecology.
    Jacobs HS; Wright CS
    Br J Hosp Med; 1978 Dec; 20(6):652-60. PubMed ID: 743578
    [No Abstract]   [Full Text] [Related]  

  • 8. A double blind controlled study of the hormonal and clinical effects of bromocriptine in the polycystic ovary syndrome.
    Buvat J; Buvat-Herbaut M; Marcolin G; Racadot A; Fourlinnie JC; Beuscart R; Fossati P
    J Clin Endocrinol Metab; 1986 Jul; 63(1):119-24. PubMed ID: 3519644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Remote results of treatment of galactorrhea-amenorrhea syndromes and functional sterility with increased prolactin concentration by means of bromocriptine (Parlodel-Sandoz)].
    Tomala J; Dudkiewicz J; Blecharz AJ
    Ginekol Pol; 1980 Mar; 51(3):255-8. PubMed ID: 6771191
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in the prolactin and thyrotropin content as affected by thyroliberin in patients with polycystic ovaries].
    Tudose TI; Pishulin AA; Dobracheva AD; Bobrovskaia TA
    Akush Ginekol (Mosk); 1986 Nov; (11):64-7. PubMed ID: 2949662
    [No Abstract]   [Full Text] [Related]  

  • 11. [Indications for bromocriptine treatment of various forms of infertility in women and men].
    Baranowska B; Jeske W; Stopińska-Głuszak U
    Ginekol Pol; 1984 May; 55(5):345-9. PubMed ID: 6500328
    [No Abstract]   [Full Text] [Related]  

  • 12. Polycystic ovarian disease associated with hyperprolactinemia and defective metoclopramide response.
    Alger M; Vazquez-Matute L; Mason M; Canales ES; Zárate A
    Fertil Steril; 1980 Jul; 34(1):70-1. PubMed ID: 7398912
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistant cases of polycystic ovarian disease successfully treated with a combination of corticosteroids, clomiphene, and bromocriptine.
    Homburg R; Ashkenazi J; Goldman J
    Int J Fertil; 1988; 33(6):393-7. PubMed ID: 2906913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].
    Shi YH; Sheng Y; Chen ZJ; Yan JH; Gao Q; Liu H; Ma ZX
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):251-3. PubMed ID: 18843962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine in polycystic ovarian disease: a controlled clinical trial.
    el Tabbakh GH; Loutfi IA; Azab I; Rahman HA; Southren AL; Aleem FA
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):301-6. PubMed ID: 3279350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of polycystic ovary syndrome with spironolactone or bromocriptine.
    Blum I; Kaufman H; Marilus R; Rusecki Y; Chovers I
    Obstet Gynecol; 1981 May; 57(5):661-5. PubMed ID: 7219917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of bromocriptine on gonadotropin and steroid secretion in polycystic ovarian disease.
    Steingold KA; Lobo RA; Judd HL; Lu JK; Chang RJ
    J Clin Endocrinol Metab; 1986 May; 62(5):1048-51. PubMed ID: 2937800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of bromocriptine in hyperprolactinaemic anovulation and related disorders.
    Franks S
    Drugs; 1979 May; 17(5):337-48. PubMed ID: 378649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
    Parsanezhad ME; Alborzi S; Namavar Jahromi B
    Arch Gynecol Obstet; 2004 Jan; 269(2):125-9. PubMed ID: 14648180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of bromocriptine on polycystic ovary syndrome complicated by severe hypertension].
    Aiko A; Ito M; Matsuura K; Fujisaki S
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2115-8. PubMed ID: 3794462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.